Prescription and utilization patterns of adjunct treatments to levodopa in Parkinson's disease

被引：0
|
作者：
Saragoussi, Delphine
Rive, Benoit
Milea, Dominique
Toumi, Mondher
Fantino, Bruno
Verpillat, Patrice
机构：
[1] H Lundbeck & Co AS, Hlth Econ & Epidemiol, Paris, France
[2] H Lundbeck & Co AS, Prod Risk Management, Paris, France
[3] H Lundbeck & Co AS, Econ & Pricing Div, Paris, France
来源：
PHARMACOEPIDEMIOLOGY AND DRUG SAFETY | 2007年 / 16卷
关键词：
D O I：
暂无
中图分类号：
R1 [预防医学、卫生学];
学科分类号：
1004 ; 120402 ;
摘要：
472
引用
收藏
页码：S224 / S224
页数：1
相关论文
共 50 条
  • [11] Effect of rasagiline as adjunct therapy to levodopa on severity of OFF in Parkinson's disease
    Stocchi, F.
    Rabey, J. M.
    EUROPEAN JOURNAL OF NEUROLOGY, 2011, 18 (12) : 1373 - 1378
  • [12] Ropinirole used as an adjunct to levodopa is effective on motor function in Parkinson's disease
    Oztekin, N.
    Oztekin, M. F.
    Dagdelen, F.
    Acar, B.
    PARKINSONISM & RELATED DISORDERS, 2007, 13 : S107 - S107
  • [13] Contrasting gene expression patterns induced by levodopa and pramipexole treatments in the rat model of Parkinson's disease
    Taravini, Irene R.
    Larramendy, Celia
    Gomez, Gimena
    Saborido, Mariano D.
    Spaans, Floor
    Fresno, Cristobal
    Gonzalez, German A.
    Fernandez, Elmer
    Murer, Mario G.
    Gershanik, Oscar S.
    NEUROPHARMACOLOGY, 2016, 101 : 576 - 589
  • [14] Levodopa-induced dyskinesias in Parkinson's disease: emerging treatments
    Bargiotas, Panagiotis
    Konitsiotis, Spyridon
    NEUROPSYCHIATRIC DISEASE AND TREATMENT, 2013, 9 : 1605 - 1617
  • [15] An Australian multicentre open label study of pergolide as an adjunct to levodopa in Parkinson's disease
    Hely, MA
    Morris, JGL
    Burns, RJ
    Lander, CM
    McLaughlin, DB
    Donnan, GA
    JOURNAL OF CLINICAL NEUROSCIENCE, 1996, 3 (03) : 234 - 238
  • [16] Levodopa and Parkinson's disease
    Valkovic, P.
    Blazicek, P.
    Benetin, J.
    Kukumberg, P.
    CESKA A SLOVENSKA NEUROLOGIE A NEUROCHIRURGIE, 2006, 69 (03) : 183 - 188
  • [17] Levodopa treatment patterns in Parkinson's disease: A retrospective chart review
    Navaratnam, Prakash
    Arcona, Steve
    Friedman, Howard S.
    Leoni, Matthew
    Sasane, Rahul
    CLINICAL PARKINSONISM & RELATED DISORDERS, 2022, 6
  • [18] Geographic Variation in Prescription Patterns of Parkinson's Disease Medications
    Bruno, Michiko K.
    Watanabe, Gina
    Ishikawa, Kyle
    Chen, John J.
    Gao, Fay
    Nakagawa, Kazuma
    Taira, Deborah
    MOVEMENT DISORDERS, 2022, 37 (03) : 646 - 648
  • [19] Efficacy of preladenant, a novel A2A antagonist, as an adjunct to levodopa for the treatment of Parkinson's disease
    Hauser, R. A.
    Pourcher, E.
    Micheli, F.
    Mok, V.
    Onofrj, M.
    Huyck, S. B.
    Wolski, K.
    Cantillon, M.
    MOVEMENT DISORDERS, 2009, 24 : S265 - S265
  • [20] Spotlight on opicapone as an adjunct to levodopa in Parkinson's disease: design, development and potential place in therapy
    Annus, Adam
    Vecsei, Laszlo
    DRUG DESIGN DEVELOPMENT AND THERAPY, 2017, 11 : 143 - 151
12345